| |
| |
|
| Insider
Information: |
Do Hung |
| Relationship: |
Chief Science Officer |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
448,617 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,759,826 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
448,617 |
|
|
| Total
Value |
$4,759,826 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Science Officer |
2021-04-06 |
448,617 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2021-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
20,501 |
448,617 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2021-01-15 |
4 |
D |
$21.84 |
$217,477 |
D/D |
(9,960) |
428,116 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
22,458 |
438,076 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
34,572 |
415,618 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2021-01-03 |
4 |
D |
$23.09 |
$206,378 |
D/D |
(8,938) |
381,046 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2021-01-02 |
4 |
D |
$23.09 |
$331,526 |
D/D |
(14,358) |
389,984 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-12-31 |
4 |
D |
$23.09 |
$123,301 |
D/D |
(5,340) |
404,342 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-12-14 |
4 |
AS |
$23.88 |
$2,653,276 |
D/D |
(111,125) |
409,682 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-10-09 |
4 |
AS |
$15.03 |
$2,911,272 |
D/D |
(193,700) |
520,807 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-10-09 |
4 |
OE |
$8.61 |
$1,974,507 |
D/D |
193,700 |
714,507 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-06-15 |
4 |
D |
$11.14 |
$16,108 |
D/D |
(1,446) |
520,807 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,354 |
522,253 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-02-12 |
4 |
AS |
$11.01 |
$697,340 |
D/D |
(63,356) |
510,899 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-02-12 |
4 |
OE |
$5.13 |
$322,601 |
D/D |
53,100 |
574,255 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-01-10 |
4 |
D |
$9.46 |
$178,832 |
D/D |
(18,904) |
521,155 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
40,828 |
540,059 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-01-03 |
4 |
D |
$9.18 |
$85,649 |
D/D |
(9,330) |
499,231 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-01-02 |
4 |
D |
$9.55 |
$67,490 |
D/D |
(7,067) |
508,561 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
68,446 |
515,628 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-12-31 |
4 |
D |
$9.74 |
$99,533 |
D/D |
(10,219) |
447,182 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-06-14 |
4 |
D |
$11.35 |
$16,412 |
D/D |
(1,446) |
457,401 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
20,579 |
458,847 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-01-16 |
4 |
AS |
$12.05 |
$441,861 |
D/D |
(36,669) |
438,268 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-01-16 |
4 |
OE |
$2.94 |
$168,749 |
D/D |
35,024 |
474,937 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-01-15 |
4 |
AS |
$12.00 |
$199,200 |
D/D |
(16,600) |
439,913 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
